Presented at the 2025 ASCO Annual Meeting, the ROSELLA (GOG-3073 | ENGOT-OV72 | LACOG-EVA 0223) trial met its primary endpoint of improved progression-free survival, as assessed by blinded independent central review (PFS-BICR). #LACOG.#ASCO25

Renal Registry (LACOG 1120) reveals major disparities in kidney cancer care in Brazil: 5-yr OS is 79.6% (private) vs. 42% (public). Patients in the public system face later diagnoses, less access to novel therapies & worse outcomes. #ASCO25 #LACOG @ascocancer

Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.

Thank you for joining the LACOG Scientific Meeting at #ASCO2025. A great evening of science, collaboration, and commitment to advancing oncology research in Latin America. Together, we drive progress through cooperative research. #LACOG #CancerResearch #Oncology #ClinicalTrials

RT @drdanielvargas: Once again meeting the @LACOG_group board members and affiliates during the @ASCO meeting. We ahead the opportunity to….

RT @BIGxResearch: Thank you to Dr. @GustavoWerutsky , chair of @LACOG_group and member of BIG Executive Board, for his commitment to BIG an….

No dia 15 de maio de 2025, foi realizada a segunda etapa do Workshop de Pesquisa Clínica do LACOG, GBOT e GBCP. O evento tem como objetivo apoiar a formação de jovens oncologistas investigadores e fomentar o desenvolvimento de propostas de estudos. @GBOT_Alerta @gbcpoficial

Na semana passada, recebemos a visita da equipe da BeiGene, renomada multinacional da área de oncologia, com o intuito de estreitar laços e fortalecer parcerias no Brasil e na América Latina. Agradecemos pela presença e pelas trocas enriquecedoras. #LACOG #PesquisaClinica

O LACOG-GU lançou a primeira edição do Programa de Incentivo à Pesquisa (PIP). O principal objetivo é fornecer suporte e financiamento para estudos e projetos de pesquisa a serem iniciados, relacionados à oncologia geniturinária. Saiba mais em #LACOG

LACOG is honored to have two posters selected. Dr. Fernando Maluf and Dr. Pedro Isaacsson will present results from the Prostate Cancer Registry (LACOG 1818) and ExBAT trial (LACOG 0620) respectively. We invite everyone at the event to honor this important work. #ASCOGU25.#GU25

Results from the GASPAR Study (LACOG 0222) were presented as a poster at the 2025 ASCO Gastrointestinal Cancers Symposium in San Francisco (USA). This observational cohort study established a multicenter Latin American database with GAICO and GTG. #ASCOGI25.#GI25

RT @oncodaily: Disparities in the treatment of rare cancers in Latin America - Bruna David. @LACOG_group @PestanaR….

In December 2024, LACOG, @uicc, @BIGxResearch, @GustaveRoussy, @uniofwarwick and 21 additional partners signed an Grant Agreement for the Path4Young project. We are proud to be a partner of this project and to carry out collaborative and international studies for breast cancer.

RT @nataliagandur: 🌟Dear colleagues,.I kindly invite you to participate in a quick bilingual survey (English/Spanish) on the management of….

We are pleased to share the publication “Choroid plexus tumors in adults: a retrospective mono-institutional study” in Neurological Sciences, authored by Dra. @Ludmilakoch2 . Read the full article #LACOG

RT @GBECAMConnect: Nos dias 28 e 29 de março de 2025, São Paulo será palco da Conferência Brasileira de Câncer de Mama LACOG - GBECAM 2025….

Marque na sua agenda!. A Conferência Brasileira de Câncer de Mama - LACOG/GBECAM 2025 (Best of SABCS) acontecerá nos dias 28 e 29 de março de 2025 no Hotel Grand Hyatt, em São Paulo (SP). Inscreva-se gratuitamente em . @GBECAMConnect @SABCSSanAntonio

The LATINA Breast (LACOG 0615 | MO39485) was a prospective observational study that included patients from several countries in Latin America. A sub-analysis was presented as a poster by Dr. @GustavoWerutsky at the 2024 @SABCSSanAntonio. #LACOG.#SABCS24

The CHERRY-PICK Trial (LACOG 0721) aims to evaluate an anti-HER2 chemo-free neoadjuvant regimen. The study is open to patients participation in Brazil. The trial design was presented at the 2024 @SABCSSanAntonio. PI: Dr. Sergio Simon, CPO/Oncoclínicas. #LACOG.#SABCS24

The AMAZONA III (LACOG/GBECAM 0115) was a prospective cohort study that included patients newly diagnosed with invasive Breast Cancer (BC). Results from the study were presented as a poster by Dra. Daniela Rosa yesterday, at the 2024 @SABCSSanAntonio. #LACOG.#SABCS24

RT @PGrivasMDPhD: Amazing talk by Dr. Fernando Maluf (Brazil) @LACOG_group very large portfolio of trials across GU cancers! I love the #He….